BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16860504)

  • 1. Chaperone-mediated autophagy in aging and neurodegeneration: lessons from alpha-synuclein.
    Bandyopadhyay U; Cuervo AM
    Exp Gerontol; 2007; 42(1-2):120-8. PubMed ID: 16860504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.
    Pan T; Kondo S; Le W; Jankovic J
    Brain; 2008 Aug; 131(Pt 8):1969-78. PubMed ID: 18187492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein degradation, aggregation, and misfolding.
    Cuervo AM; Wong ES; Martinez-Vicente M
    Mov Disord; 2010; 25 Suppl 1():S49-54. PubMed ID: 20187257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein and Parkinson's disease: a proteomic view.
    Fasano M; Lopiano L
    Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy: many paths to the same end.
    Cuervo AM
    Mol Cell Biochem; 2004 Aug; 263(1-2):55-72. PubMed ID: 15524167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snaring the function of alpha-synuclein.
    Bonini NM; Giasson BI
    Cell; 2005 Nov; 123(3):359-61. PubMed ID: 16269324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagic pathways in Parkinson disease and related disorders.
    Xilouri M; Stefanis L
    Expert Rev Mol Med; 2011 Mar; 13():e8. PubMed ID: 21418705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chaperone-mediated autophagy in aging and disease.
    Massey AC; Zhang C; Cuervo AM
    Curr Top Dev Biol; 2006; 73():205-35. PubMed ID: 16782460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of chaperone-mediated autophagy.
    Massey A; Kiffin R; Cuervo AM
    Int J Biochem Cell Biol; 2004 Dec; 36(12):2420-34. PubMed ID: 15325582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of autophagy in age-related neurodegeneration.
    McCray BA; Taylor JP
    Neurosignals; 2008; 16(1):75-84. PubMed ID: 18097162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein and autophagy as common steps in neurodegeneration.
    Ferrucci M; Pasquali L; Ruggieri S; Paparelli A; Fornai F
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S180-4. PubMed ID: 18583174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain.
    Keller JN; Dimayuga E; Chen Q; Thorpe J; Gee J; Ding Q
    Int J Biochem Cell Biol; 2004 Dec; 36(12):2376-91. PubMed ID: 15325579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein folding and misfolding in the neurodegenerative disorders: a review.
    Bolshette NB; Thakur KK; Bidkar AP; Trandafir C; Kumar P; Gogoi R
    Rev Neurol (Paris); 2014 Mar; 170(3):151-61. PubMed ID: 24613386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C; Lee SJ
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of glutamatergic signaling to nitrosative stress-induced protein misfolding in normal brain aging and neurodegenerative diseases.
    Nakamura T; Gu Z; Lipton SA
    Aging Cell; 2007 Jun; 6(3):351-9. PubMed ID: 17388798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
    Schnack C; Danzer KM; Hengerer B; Gillardon F
    Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement.
    Pan T; Kondo S; Zhu W; Xie W; Jankovic J; Le W
    Neurobiol Dis; 2008 Oct; 32(1):16-25. PubMed ID: 18640276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.